GO:0036005 response to macrophage colony-stimulating factor: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036005 (response to macrophage colony-stimulating factor) describes any cellular or organismal change triggered by M-CSF (CSF1), including movement, secretion, enzyme production, and gene expression.
• M-CSF signals primarily through its receptor CSF1R, driving monocyte/macrophage proliferation, survival, and differentiation.
• The M-CSF response signature is clinically relevant in breast carcinoma, where it correlates with macrophage infiltration and poor prognosis.
• In the brain, M-CSF and CSF1R are expressed by activated microglia and are linked to teratogen-induced neuronal damage.
• Hyperglycemia augments macrophage growth responses to CSF1, connecting metabolic state to this pathway.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of M-CSF response genes in immune and cancer biology.
Description
GO:0036005, response to macrophage colony-stimulating factor, is a biological process defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus. Macrophage colony-stimulating factor (M-CSF, also known as CSF1) is a cytokine that controls the proliferation, differentiation, and survival of mononuclear phagocytes. The response to M-CSF is therefore central to innate immunity, tissue homeostasis, and pathological macrophage activation. Researchers study GO:0036005 to understand how macrophages and their precursors sense and respond to M-CSF in development, infection, and cancer. The M-CSF/CSF1R axis is a major regulator of the mononuclear phagocyte system, and its dysregulation is implicated in tumor progression, neuroinflammation, and bone remodeling. Because M-CSF responses are context-dependent, precise experimental models are needed to dissect the underlying signaling and transcriptional programs. This article provides a research-grade overview of GO:0036005, covering its definition, core mechanisms, key genes, disease relevance, and state-of-the-art methods including CRISPR genome editing. All statements are grounded in the verified literature cited by number.
response to macrophage colony-stimulating factor At A Glance
| GO ID | GO:0036005 |
|---|---|
| GO term | response to macrophage colony-stimulating factor |
| Ontology | biological_process |
| Synonym | response to macrophage colony-stimulating factor stimulus; response to M-CSF |
| Major function | Cellular and organismal response to M-CSF (CSF1) stimulation, including proliferation, survival, differentiation, and gene expression changes |
| Key receptor | CSF1R (M-CSF receptor) |
| Primary cell types | Monocytes, macrophages, microglia, osteoclasts, and their precursors |
| Disease relevance | Breast carcinoma, neuroinflammation, bone disorders, and metabolic stress |
| Research methods | Knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, imaging |
What Is GO:0036005?
In simple terms, GO:0036005 is the set of changes a cell undergoes after it encounters macrophage colony-stimulating factor (M-CSF). According to the QuickGO definition, it is any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a macrophage colony-stimulating factor stimulus. This includes rapid signaling events, transcriptional reprogramming, and longer-term phenotypic changes such as proliferation or differentiation.
Why Is response to macrophage colony-stimulating factor Important in Cell Biology?
GO:0036005 is important because M-CSF is a master regulator of mononuclear phagocyte development and function, and its response pathway influences immunity, tissue repair, bone remodeling, and cancer progression. Understanding this process helps researchers identify therapeutic targets for diseases driven by macrophage dysfunction, such as breast cancer, neuroinflammatory conditions, and osteopetrosis.
• Controls monocyte and macrophage proliferation, survival, and differentiation.
• Shapes the tumor microenvironment in breast carcinoma through an M-CSF response signature.
• Regulates microglial activation and neuroinflammation in the brain.
• Influences bone regeneration via osteomacs (bone macrophages).
• Is modulated by metabolic state, such as hyperglycemia.
• Provides a model for studying cytokine-driven gene expression programs.
• Serves as a target for CRISPR-based functional genomics in immune cells.
• Links innate immunity to tissue homeostasis and disease.
What Happens During response to macrophage colony-stimulating factor?
M-CSF Binding and Receptor Activation
In simple terms: M-CSF binds to its receptor on the cell surface, switching it on.
The response to M-CSF begins when macrophage colony-stimulating factor (CSF1) binds to its receptor, CSF1R, a receptor tyrosine kinase. This binding induces receptor dimerization and autophosphorylation, initiating intracellular signaling cascades. In microglia, overexpression of the M-CSF receptor induces an inflammatory response, indicating that receptor levels modulate the strength of the response.
Intracellular Signaling and Gene Expression
In simple terms: Signals travel inside the cell and turn genes on or off.
Activated CSF1R triggers phosphorylation of downstream effectors, leading to changes in gene expression that drive proliferation and survival. The M-CSF response signature in breast carcinoma includes genes involved in macrophage function and tumor progression. This transcriptional reprogramming is a hallmark of the response to M-CSF.
Proliferation and Survival
In simple terms: The cell receives growth and survival signals.
M-CSF is a mitogen for macrophages, promoting cell cycle entry and survival. Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1, showing that metabolic context can enhance this proliferative response. This proliferative response is central to the expansion of macrophage populations during immune responses.
Differentiation and Functional Polarization
In simple terms: Cells mature and take on specialized jobs.
M-CSF drives the differentiation of monocytes into macrophages and influences their functional phenotype. Granulocyte/macrophage colony-stimulating factor-derived macrophages exhibit a distinct early immune response to lymphocytic choriomeningitis virus infection, highlighting how cytokine context shapes macrophage function. In bone, osteomacs are a specialized macrophage population that supports bone regeneration.
Microglial Activation and Neuroinflammation
In simple terms: In the brain, M-CSF response can trigger inflammation.
Microglia express M-CSF and its receptor, and their activation is linked to teratogen-induced neuronal damage. Overexpression of the M-CSF receptor on microglial cells induces an inflammatory response, demonstrating a direct role for this pathway in neuroinflammation. Chimeric models allow study of human microglia in vivo, providing a platform to dissect M-CSF responses in the brain.
Key Genes Involved in GO:0036005 response to macrophage colony-stimulating factor
The following genes and proteins are central to the response to macrophage colony-stimulating factor (GO:0036005).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF1 | Ligand; macrophage colony-stimulating factor | Stimulus for GO:0036005; studied in cancer and neuroinflammation |
| CSF1R | Receptor tyrosine kinase for CSF1 | Mediates M-CSF signaling; overexpressed in microglia to induce inflammation |
| GRN | Granulin precursor; involved in macrophage function | Linked to M-CSF response in breast carcinoma signature |
| SPP1 | Osteopontin; secreted phosphoprotein | Part of M-CSF response signature in breast cancer |
| CTSB | Cathepsin B; lysosomal protease | Associated with macrophage activation in M-CSF response |
| CTSS | Cathepsin S; antigen processing | M-CSF response signature gene in breast carcinoma |
| MMP12 | Matrix metalloproteinase 12 | Macrophage-specific; part of M-CSF response |
| CCL2 | Monocyte chemoattractant protein-1 | Chemokine involved in macrophage recruitment; M-CSF response |
| IL1B | Interleukin-1 beta | Pro-inflammatory cytokine induced in M-CSF response |
| TNF | Tumor necrosis factor | Inflammatory cytokine linked to M-CSF response |
| CD68 | Macrophage marker | Used to identify macrophages in M-CSF studies |
| ITGAM | Integrin alpha M (CD11b) | Macrophage marker; M-CSF response |
| LYZ | Lysozyme | Macrophage effector; M-CSF response |
| PTPRC | CD45; protein tyrosine phosphatase receptor type C | Immune cell marker; M-CSF response |
| CSF2 | Granulocyte-macrophage colony-stimulating factor | Related cytokine; distinct macrophage responses |
| TREM2 | Triggering receptor expressed on myeloid cells 2 | Microglial receptor; M-CSF response in brain |
| C1QA | Complement C1q A chain | Microglial marker; M-CSF response |
| CX3CR1 | Fractalkine receptor | Microglial marker; M-CSF response |
How Is response to macrophage colony-stimulating factor Regulated?
The response to M-CSF is regulated at multiple levels. Receptor availability and activity are controlled by CSF1R expression levels, as overexpression of CSF1R on microglial cells induces an inflammatory response. Metabolic state can modulate the response, as hyperglycemia augments macrophage growth responses to CSF1. Additionally, the cytokine environment influences the response, with GM-CSF-derived macrophages showing distinct early immune responses compared to M-CSF-derived macrophages. These regulatory layers ensure context-specific outcomes of M-CSF stimulation.
response to macrophage colony-stimulating factor and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF1 | Breast carcinoma; macrophage infiltration | CSF1 knockout in breast cancer cell lines; xenograft models |
| CSF1R | Neuroinflammation; microglial activation | CSF1R overexpression in microglial cells; knock-in mouse models |
| GRN | Breast carcinoma; M-CSF response signature | GRN knockout in macrophage cell lines; RNA-seq |
| SPP1 | Breast carcinoma; tumor progression | SPP1 knockout in breast cancer cells; invasion assays |
| TREM2 | Neurodegeneration; microglial function | TREM2 knock-in humanized microglia models |
Breast Carcinoma
The M-CSF response signature is associated with breast carcinoma, where it correlates with macrophage infiltration and poor prognosis. This signature includes genes involved in macrophage function and tumor progression, suggesting that M-CSF response in the tumor microenvironment promotes malignancy.
Neuroinflammation and Neuronal Damage
In the brain, M-CSF and its receptor are expressed by activated microglia, and this activation is linked to teratogen-induced neuronal damage. Overexpression of the M-CSF receptor on microglial cells induces an inflammatory response, implicating the M-CSF pathway in neuroinflammatory diseases.
Bone Disorders and Regeneration
Osteomacs, a specialized macrophage population in bone, are involved in bone regeneration and are regulated by M-CSF. Dysregulation of M-CSF responses may contribute to bone disorders, and osteomacs are a potential target for therapeutic bone regeneration.
Metabolic Stress
Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1, linking metabolic stress to enhanced M-CSF responses. This may contribute to macrophage dysfunction in diabetes and related metabolic disorders.
From response to macrophage colony-stimulating factor-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CSF1R mediate M-CSF-induced proliferation? | CSF1R knockout in macrophage cell lines |
| What is the effect of a point mutation in CSF1R on signaling? | Point mutation knock-in via CRISPR in primary macrophages |
| How does M-CSF response differ in human microglia? | Chimeric model with human microglia in vivo |
| Can overexpression of CSF1R induce inflammation? | CSF1R overexpression in microglial cells |
| What genes are part of the M-CSF response signature? | RNA-seq after M-CSF stimulation in macrophages |
| Does hyperglycemia alter M-CSF response? | In vitro macrophage culture under high glucose |
How to Study the response to macrophage colony-stimulating factor Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify M-CSF response genes |
| Proteomics | Protein abundance and modifications | Map signaling pathways |
| Flow cytometry | Surface marker expression | Assess macrophage differentiation |
| Immunofluorescence | Protein localization and activation | Visualize microglial activation |
| CRISPR knockout screening | Gene essentiality | Find regulators of M-CSF response |
| Phospho-tyrosine immunoblot | Receptor activation | Measure CSF1R phosphorylation |
| Cell proliferation assay | Growth response | Quantify M-CSF-induced proliferation |
Transcriptomic Profiling
RNA-seq and microarray analysis can identify gene expression changes during the response to M-CSF. The M-CSF response signature in breast carcinoma was defined using such approaches. These methods reveal the transcriptional programs activated by M-CSF.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein abundance and phosphorylation changes downstream of CSF1R activation. This helps map signaling networks in the M-CSF response.
Imaging and Flow Cytometry
Flow cytometry can measure surface markers like CD68 and CD11b to assess macrophage differentiation in response to M-CSF. Imaging can visualize microglial activation in brain models.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes required for M-CSF-induced proliferation or survival. This unbiased approach can uncover novel regulators of GO:0036005.
How CRISPR Can Be Used to Study GO:0036005 response to macrophage colony-stimulating factor
Knockout
CRISPR knockout of CSF1R or downstream effectors can abolish the response to M-CSF, confirming their essential roles. Knockout models are valuable for dissecting the signaling cascade.
Point Mutation
Introducing point mutations in CSF1R or signaling intermediates via CRISPR can reveal residues critical for M-CSF response. This approach helps distinguish kinase-dependent and independent functions.
Knock-in
Knock-in of tagged or humanized versions of CSF1R or other genes can enable tracking and functional studies in vivo. Chimeric models with human microglia rely on knock-in strategies.
Overexpression
Overexpression of CSF1R in microglial cells induces an inflammatory response, demonstrating gain-of-function effects. CRISPR activation (CRISPRa) can achieve targeted overexpression for studying M-CSF response.
How EDITGENE Supports response to macrophage colony-stimulating factor Research
Researchers studying response to macrophage colony-stimulating factor-related genes often need to determine whether a candidate gene is causally involved in M-CSF signaling, proliferation, or differentiation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for response to macrophage colony-stimulating factor research.
Frequently Asked Questions About response to macrophage colony-stimulating factor
What is GO:0036005?
GO:0036005 is the biological process 'response to macrophage colony-stimulating factor', defined as any cellular or organismal change resulting from an M-CSF stimulus.
What genes are involved in response to macrophage colony-stimulating factor?
Key genes include CSF1 (the ligand), CSF1R (the receptor), and downstream effectors such as GRN, SPP1, and cathepsins.
What is the role of CSF1R in M-CSF response?
CSF1R is the receptor tyrosine kinase that binds M-CSF and initiates signaling cascades leading to proliferation, survival, and differentiation.
How is response to M-CSF studied?
Common methods include RNA-seq, proteomics, flow cytometry, and CRISPR screens.
What diseases are linked to M-CSF response?
Breast carcinoma, neuroinflammation, bone disorders, and metabolic stress are associated with M-CSF response.
Can CRISPR be used to study M-CSF response?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect M-CSF signaling.
What is the M-CSF response signature in breast cancer?
It is a gene expression signature associated with macrophage infiltration and poor prognosis in breast carcinoma.
How does hyperglycemia affect M-CSF response?
Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1.
What are osteomacs?
Osteomacs are bone macrophages involved in bone regeneration and regulated by M-CSF.
What is the difference between M-CSF and GM-CSF responses?
M-CSF and GM-CSF drive distinct macrophage activation states and early immune responses.
Conclusion
GO:0036005, response to macrophage colony-stimulating factor, is a fundamental biological process that governs macrophage and microglial biology in health and disease. Its dysregulation contributes to cancer, neuroinflammation, and bone disorders, making it a compelling target for therapeutic intervention. CRISPR-based models and multi-omics approaches are essential for dissecting the underlying mechanisms and identifying new drug targets. EDITGENE offers end-to-end CRISPR services to help researchers uncover the complexities of M-CSF response and translate findings into clinical applications.
References
- 1. Alothaimeen T et al.. 2020. Granulocyte/Macrophage Colony-Stimulating Factor-Derived Macrophages Exhibit Distinctive Early Immune Response to Lymphocytic Choriomeningitis Virus Infection.. Viral Immunol 33(6):477-488 PMID: 32255741
- 2. Hasselmann J et al.. 2019. Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.. Neuron 103(6):1016-1033.e10 PMID: 31375314
- 3. Beck AH et al.. 2009. The macrophage colony-stimulating factor 1 response signature in breast carcinoma.. Clin Cancer Res 15(3):778-87 PMID: 19188147
- 4. Sherr CJ. 1991. Mitogenic response to colony-stimulating factor 1.. Trends Genet 7(11-12):398-402 PMID: 1840317
- 5. Batoon L et al.. 2017. Osteomacs and Bone Regeneration.. Curr Osteoporos Rep 15(4):385-395 PMID: 28647885
- 6. Mitrasinovic OM et al.. 2001. Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response.. J Biol Chem 276(32):30142-9 PMID: 11387343
- 7. Saini A et al.. 1996. Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1.. Metabolism 45(9):1125-9 PMID: 8781300
- 8. Hao AJ et al.. 2002. Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage.. Neuroscience 112(4):889-900 PMID: 12088748
